What is Testosterone Decanoate?
Testosterone Decanoate is testosterone with a ten-carbon decanoate ester attached. The long ester makes the molecule very fat-soluble, so it stays in the oil depot for a long time and enters the blood slowly. Decanoate is best known as the long component of ester blends such as Sustanon; here it comes as a single ester at 300 mg/ml.
In the body the ester is cleaved off and plain testosterone remains. The effect is no different from enanthate, only the release is slower and steadier.
This information is for research and educational purposes only. No medical advice.
Comparison
Short and long esters
The same compound at the same receptor with esters of different length, as stated in the TPD lexicon. Tap a card to open its entry.
How it works
Testosterone binds the androgen receptor in muscle, bone and many other tissues. Studies show dose-dependent gains in fat-free mass, muscle cross-section and strength, along with more nitrogen retention and stronger red blood cell production.
Part of it is converted to estradiol by aromatase and part to DHT by 5-alpha reductase. That is why estrogen issues and androgenic effects such as acne come with every testosterone ester. The decanoate ester has no effect of its own; it only sets how fast testosterone leaves the depot.
Where it acts
One receptor, several organs
Tap a point or a card. Grey = effect seen in trials.
- Hypothalamus and pituitary
LH and FSH fell quickly and kept falling1
Observed in trials - Testes
Sperm production suppressed, recovered after stopping2
Observed in trials - Blood
Haemoglobin +9 percent, haematocrit +15 percent1
Observed in trials - Liver
Raised liver values in some men, study stopped early1
Observed in trials - Skeletal muscle
Fat-free mass rose with the testosterone level, study with enanthate5
Observed in trials
Targets in the ChEMBL database8
Compound CHEMBL386630: one recorded mechanism, Testosterone once the ester is split off: agonist, direct binding.
- Gene
- AR
- UniProt
- P10275
- ChEMBL
- CHEMBL1871
- Action
- Testosterone once the ester is split off: agonist, direct binding
Use and dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
Injection
The oil is ready to use and is not mixed. The usual route is intramuscular into the glute, thigh or shoulder; disinfect the site first and rotate sites regularly.
- Thicker needle to draw, thinner needle to inject.
- Subcutaneous works for small volumes, at most about 0.5 ml per site, injected slowly.
- Small lumps after subcutaneous shots are common and usually fade within a few days.
What the research shows
Decanoate has mainly been studied in male hormonal contraception. Anderson and colleagues (Contraception, 2002) gave 400mg every four weeks together with etonogestrel: trough levels rose with each injection, LH and FSH fell quickly, hemoglobin went up 9 percent and hematocrit 15 percent.
The larger phase IIb trial by Hay and colleagues (JCEM, 2005) compared four- and six-week intervals over 48 weeks. With four weeks, trough levels sat in the normal range. After stopping, sperm counts and gonadotropins recovered in both groups.
A doping control study with an ester mix showed that detection time in blood depends on the ester, with the long esters lasting longest. Kicman (Br J Pharmacol, 2008) summarizes the general pharmacology of esterification.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Suppressed sperm production after 12 weeks1
Share of the 20 men, injection every 4 weeks plus progestin implant
In the larger phase IIb study all men but one were below 1 million per ml after 48 weeks. After stopping, sperm counts and gonadotropins recovered in both groups. Research data, not a contraceptive.
Rise in red blood values1
Change in percent, 20 men, injection every 4 weeks plus progestin implant
Body weight rose too. The study was stopped after 12 to 18 weeks because some men had raised liver values.
Fat-free mass after 20 weeks5
Gain in kg in the three higher of five dose levels, study with enanthate
Same testosterone, different ester. Strength, haemoglobin and muscle volume rose with the level while fat mass and HDL cholesterol fell.
Research status
Where the research stands
There is no registered trial with the single ester. Shown are trials with the approved blend of four testosterone esters, in which decanoate is the longest component. As of 26 Oct 2026. 7
- Preclinical Pharmacology of esterification and depot action
- Phase 1 1 trial, 0 completed
- Phase 2 no registered trial
- Phase 3 1 trial, 1 completed
- Approval not as a single ester
Show all 9 phase 3 and 4 trials on a timelineHide timeline
CDGP · NCT01797718 · 35 participants, started Oct 2013, primary endpoint reached Mar 2017. Tests several agents.
Registry entry ↗ · Results not yet in PubMed
NCT00355537 · 19 participants, started Feb 2006, primary endpoint reached Dec 2009.
Registry entry ↗ · Results not yet in PubMed
NCT01107067 · 32 participants, started Jun 2008, primary endpoint reached Dec 2009.
Registry entry ↗ · Results not yet in PubMed
NCT01533129 · 106 participants, started Aug 2008, primary endpoint reached Apr 2011. Tests several agents.
Registry entry ↗ · Results not yet in PubMed
NCT02171390 · 130 participants, started Aug 2008, primary endpoint reached Jun 2012.
Registry entry ↗ · Results not yet in PubMed
NCT01454011 · 140 participants, started Sept 2008, primary endpoint reached Feb 2011. Tests several agents.
Registry entry ↗ · Results not yet in PubMed
NCT02111473 · 49 participants, started May 2009, primary endpoint reached May 2012.
Registry entry ↗ · Results not yet in PubMed
NCT01160341 · 312 participants, started Aug 2009, primary endpoint reached Jan 2010.
Registry entry ↗ · Results not yet in PubMed
NCT02111434 · 150 participants, started Jul 2013, primary endpoint reached Apr 2014.
Registry entry ↗ · Results not yet in PubMed
Bar: start to primary endpoint (planned for running trials). Green = completed, blue = progress until 26 Oct 2026. Phase 1: 1 trial on safety and pharmacokinetics, not shown as bars.
Side effects
Decanoate shares the risk profile of every testosterone ester; the long ester only changes the pace. Because the compound stays in the depot for a long time, side effects also fade more slowly after stopping.
- Estrogen: water retention, rising blood pressure, gyno risk with high aromatization.
- Hematocrit: rises with the dose, keep an eye on the blood count.
- HPTA suppression: LH, FSH and sperm production are suppressed and the testes can shrink.
- Lipids: HDL falls as the dose goes up.
- Androgenic: acne, oily skin, hair loss if predisposed.
Practice
Testosterone, estradiol, hematocrit, lipids and liver values are usually checked before the start and every few weeks. An aromatase inhibitor is used only according to bloodwork, not by default. Because decanoate keeps acting for a long time, a post-cycle plan starts later than with short esters.
- Banned in official competition (WADA S1).
- Detectable for a long time, even weeks after the last dose.
Storage
Keep the oil at room temperature, in the dark and tightly closed. Do not put it in the fridge, as the compound can crystallize in the cold. If crystals do show up, warm the vial (in your hand or in warm water) and swirl until the solution is clear again.